The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 350:2711-2712 June 24, 2004 Number 26
NextNext

Curing Cancer with p53
David Lane, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The activity of the p53 tumor-suppressor protein has a key role in controlling both cancer and aging: underactivity encourages the growth of cancer, and overactivity can accelerate the aging process. In most tumor cells, the p53 protein is inactivated by mutation, whereas in some others its function is blocked in other ways. Restoring the function of p53 to tumor cells is the dream of many investigators,1 and Snyder and colleagues2 show how well this can work by demonstrating that a p53-activating molecule can save the lives of mice carrying very aggressive disseminated cancer. What are the prospects for developing this . . . [Full Text of this Article]


Source Information

From the Department of Surgery and Molecular Oncology, University of Dundee, Dundee, United Kingdom.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.